SOURCE: StockCall

StockCall

November 08, 2011 08:00 ET

Equity Research on Teva Pharmaceutical Industries Limited and Forest Laboratories Inc. - Acquisitions, Joint Ventures and New Products Dominate Drug Manufacturer News

JOHANNESBURG, SOUTH AFRICA--(Marketwire - Nov 8, 2011) - www.stockcall.com/ offers investors comprehensive research on the Drug Manufacturers - Other industry and has completed analytical research on Teva Pharmaceutical Industries Limited (NASDAQ: TEVA) and Forest Laboratories Inc. (NYSE: FRX). Register with us today at www.stockcall.com/ to have free access to these researches.

The Drug Manufacturers - Other industry has been a hive of activity recently, with patent expiries, company takeovers and new products all factoring into the industry outlook. Companies such as Teva Pharmaceuticals Industries Ltd. have been busy of late with foreign expansions and domestic partnerships. Teva and Proctor & Gamble Co. have announced the particulars of their new joint venture which will be involved in bringing branded generic products to market. Teva Pharmaceutical Industries Limited research report is accessible for free by registering today at www.stockcall.com/TEVA081111.pdf.

www.stockcall.com/ is an online platform where investors doing their due-diligence on the Drug Manufacturers - Other industry can have easy and free access to our analyst research and opinions on Teva Pharmaceutical Industries Limited and Forest Laboratories Inc.; investors and shareholders of these companies can simply register for a complimentary membership at https://stockcall.com/development/stockcall/page.php?name=register.html.

While new markets and joint ventures can benefit companies, the industry relies heavily on research and development. Many new products have recently been announced by a plethora of companies in the industry, including Forest Laboratories Inc. The company, together with Ironwood Pharmaceuticals Inc., has recently stated that their new drug application, involving the treatment of irritable bowel syndrome, has been accepted for FDA review. Forest Laboratories Inc. research report is available for free by signing up now at www.stockcall.com/FRX081111.pdf.

As companies in the Drug Manufacturers - Other industry continue to make headlines it will be interesting to see which development strategy works best when year-end reports are released. Register now at https://stockcall.com/development/stockcall/page.php?name=register.html to have free access to our reports on the Drug Manufacturers - Other industry.

About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information